XRCC4 and lip and oral cavity carcinoma: As for oral cancer, those who had heterozygous del/ins at XRCC4 intron 3 (rs28360071) showed a 1.57-fold (95% confidence interval = 1.12-2.21) increased risk of oral cancer compared to those with ins/ins [7].